Why are nitrates effective in treating angina?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Why Nitrates Are Effective in Treating Angina

Nitrates work primarily by reducing myocardial oxygen demand through venodilation and preload reduction, while also dilating coronary arteries to improve blood flow to ischemic areas. 1

Mechanism of Action

Nitrates undergo enzymatic denitrification by mitochondrial aldehyde dehydrogenase in the vessel wall, producing vasoactive nitric oxide that causes vasodilation. 1 This mechanism operates through distinct dose-dependent effects:

Low-Dose Effects (Primary Mechanism)

  • Predominantly venodilation, reducing preload and venous return to the heart 1
  • Decreases ventricular volume and myocardial wall tension 1
  • Lowers myocardial oxygen demand - this is the prevailing mechanism in chronic stable angina and distinguishes nitrates from beta-blockers and calcium channel blockers 1, 2

High-Dose Effects (Additional Benefits)

  • Dilate coronary arteries, including pre- and poststenotic vessels and eccentric lesions 1
  • Prevent coronary artery spasm - particularly beneficial in patients with vasospastic or mixed angina 1
  • Improve subendocardial blood flow to ischemic areas 1
  • Decrease ventricular diastolic pressure and lower blood pressure 1
  • Enhance collateral blood flow 1, 2

Clinical Efficacy

Symptom Relief

  • Short-acting nitrates are recommended for immediate relief of angina (Class I, Level B recommendation) 3
  • Reduce angina attacks by approximately 2.89 episodes weekly with continuous administration and 1.5 episodes weekly with intermittent administration 4
  • Prolong exercise duration by 31 seconds with intermittent regimens and 53 seconds with continuous regimens 4

Unique Advantages

  • Vasodilatory effects are independent of endothelial integrity, as nitrates undergo bioconversion into nitric oxide in both endothelial cells and myocytes 1
  • This makes them potentially valuable in patients with endothelial dysfunction, serving as a physiological substitute for endothelium-derived relaxing factor 1, 2
  • Particularly effective in patients with coronary artery spasm, providing clear benefit in symptom reduction 1

Important Clinical Caveats

Tolerance Development

  • Continuous or frequent daily use leads to nitrate tolerance, with loss of anti-ischemic effects 2, 5
  • A nitrate-free interval (typically 10-12 hours) is required to prevent tolerance development 2, 5
  • Once-daily high-dose sustained-release formulations prevent tolerance while maintaining efficacy 2

Limitations

  • Small arterioles are nitrate-resistant, explaining why nitrates have no action in the microcirculation 1
  • Results have been disappointing in pure microvascular angina without overlapping spasm 1
  • No data support that nitrates improve outcomes (mortality or major adverse cardiac events) in chronic stable angina 1
  • Emerging evidence suggests chronic use of long-acting nitrates might cause endothelial dysfunction and increased cardiovascular risk in some patients 6

Reflex Effects

  • Preload and afterload reduction can be offset by reflex sympathetic activity, increasing heart rate and myocardial contractility 1
  • Combining nitrates with beta-blockers blocks reflex tachycardia, leading to synergistic anti-ischemic effects 1

Contraindications

  • Not recommended in patients with hypertrophic cardiomyopathy 3
  • Contraindicated with phosphodiesterase inhibitors 3
  • Should be used with caution when combined with other vasodilators in chronic stable angina 1

Guideline-Recommended Use

According to the 2024 ESC Guidelines, long-acting nitrates should be considered as add-on therapy in patients with inadequate symptom control on beta-blockers and/or calcium channel blockers, or as part of initial treatment in properly selected patients (Class IIa, Level B). 3 The most common adverse effect is headache, occurring in approximately 51.6% of patients. 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.